Is there a relationship between insulin resistance and frailty syndrome?

Current Pharmaceutical Design

Volumn 14, Issue 4, 2008, Pages 405-410

  Abbatecola, Angela Marie ^a   Paolisso, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Aging; Frailty syndrome; Insulin resistance

Indexed keywords

C REACTIVE PROTEIN; CALCIUM CHANNEL L TYPE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

AGING; BODY MASS; CAUSAL ATTRIBUTION; CHRONIC INFLAMMATION; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE ASSOCIATION; FRAIL ELDERLY; FRAILTY SYNDROME; GROWTH, DEVELOPMENT AND AGING DISORDERS; HUMAN; INSULIN RESISTANCE; MUSCLE ATROPHY; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; WALKING DIFFICULTY; AGED; ANIMAL; METABOLISM; PHYSIOLOGY; SKELETAL MUSCLE; SYNDROME;

AGED; ANIMALS; FRAIL ELDERLY; HUMANS; INSULIN RESISTANCE; MUSCLE WEAKNESS; MUSCLE, SKELETAL; SYNDROME;

EID: 42049091717     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208783497750     Document Type: Review

References (57)

1. Gumbiner B, Thorburn AW, Ditzler TM, Bulacan F, Henry RR. Role of impaired intracellular glucose metabolism in the insulin resistance of aging. Metabolism 1992; 41(10): 1115-21.
2. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 1996; 45(7): 947-53.
3. Fink RI, Kolterman OG, Griffin J, Olefsky JM. Mechanisms of insulin resistance in aging. J Clin Invest 1983; 71(6): 1523-35.
4. Barbieri M, Rizzo MR, Manzella D, Paolisso G. Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians. Diabetes Metab Res Rev 2001; 17(1): 19-26.
5. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365(9468): 1415-28.
6. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24(4): 683-9.
7. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237-42.
8. Bortz WM Ii. The physics of frailty. J Am Geriatr Soc 1993; 41: 1004-8.
9. Hamerman D. Toward an understanding of frailty. Ann Intern Med 1999; 130: 945-50.
10. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Cardiovascular Health Study Collaborative Research Group Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56(3): M146-56.
11. Vanitallie TB. Frailty in the elderly: contributions of sarcopenia and visceral protein depletion. Metabolism 2003; 52(10 Suppl 2): 22-6.
12. Guralnik JM, Simonsick EM, Ferucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994: 49(2): M85-94.
13. Ferrucci L, Cavazzini C, Corsi A, Bartali B, Russo CR, Lauretani F, et al. Biomarkers of frailty in older persons. J Endocrinol Invest 2002; 25: 10-5.
14. Lazarus R, Sparrow D, Weiss T. Handgrip strength and insulin levels: cross-sectional and prospective associations in the normative aging study. Metabolism 1997; 11: 1266-69.
15. Gregg EW, Beckles GL, Williamson DF, Leveille SG, Langlois JA, Engelgau MM, et al. Diabetes and physical disability among older U.S. adults. Diabetes Care 2000; 23(9): 1272-7.
16. Volpato S, Blaum C, Resnick H, Ferrucci L, Fried LP, Guralnik JM. Women's Health and Aging Study- Comorbidities and impairments explaining the association between diabetes and lower extremity disability: The Women's Health and Aging Study. Diabetes Care 2002; 25(4): 678-83.
17. Schwartz AV, Hillier FA, Sellmeyer DE, Resnick HE, Gregg E, Ensrud KE, et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 2002; 25(10): 1749-54.
18. Volpato S, Ferrucci L, Blaum C, Ostir G, Cappola A, Fried LP, et al. Progression of lower-extremity disability in older women with diabetes: the Women's Health and Aging Study. Diabetes Care 2003; 1: 70-5.
19. Abbatecola AM, Paolisso G, Lamponi M, Bandinelli S, Lauretani F, Launer L, et al. Insulin resistance and executive dysfunction in older persons. J Am Geriatr Soc 2004; 52: 1713-8.
20. Geroldi C, Frisoni GB, Paolisso G, Bandinelli S, Lamponi M, Abbatecola AM, et al. Insulin resistance in cognitive impairment: the InCHIANTI study. Arch Neurol 2005; 62(7): 1067-72.
21. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Paolisso G, et al. Insulin resistance and muscle strength in older persons. J Gerontol A Biol Sci Med Sci 2005; 10: 1278-82.
22. Abbatecola AM, Rizzo MR, Barbieri M, Grella R, Arciello A, Laieta MT, et al. Post-prandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics. Neurology 2006; 67(2): 235-40.
23. Song XM, Ryder JW, Kawano Y, Chibalin AV, Krook A, Zierath JR. Muscle fiber type specificity in insulin signal transduction. Am J Physiol 1999; 277: R1690-6.
24. Staron RS, Hagerman FC, Hikida RS, Murray TF, Hostler DP, Crill MT, et al. Fiber type composition of the vastus lateralis muscle of young men and women. J Histochem Cytochem 2000; 48: 623-9.
25. Krivickas LS, Suh D, Wilkins J, Hughes VA, Roubenoff R, Frontera WR. Age- and gender- related differences in maximum shortening velocity of skeletal muscle fibers. Am J Phys Med Rehabil 2001; 80: 447-55.
26. Cai D, Frantz JD, Tawa NE Jr, Melendez PA, Oh BC, Lidov HG, et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 2004; 119(2): 285-98.
27. Sriwijitkamol A, Christ-Roberts C, Berria R, Eagan P, Pratipanawatr T, DeFronzo RA, et al. Reduced skeletal muscle inhibitor of kappaB beta content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training. Diabetes 2006; 55(3): 760-7.
28. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001; 293(5535): 1673-7.
29. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002; 51(7): 2005-11.
30. Shoelson SE, Lee J, Yuan M. Inflammation and the IKK beta/I kappa B/ NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 2003; 3: S49-52.
31. Paolisso G, Gambardella A, Balbi V, Galzerano D, Verza M, Varricchio M, et al. Effects of magnesium and nifedipine infusions on insulin action, substrate oxidation and blood pressure in aged hypertensive patients. Am J Hypertens 1993; 6: 920-6.
32. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 1990; 85(6): 1844-52.
33. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996: 1(97): 2601-10.
34. Meneilly GS, Elliot T, Bryer-Ash M, Floras JS. Insulin-mediated increase in blood flow is impaired in the elderly. J Clin Endocrinol Metab 1995; 80: 1899-903.
35. Abbatecola AM, Lauretani F, Bandinelli S, Guralnik J, Paolisso G, Ferrucci L. Insulin resistance increases the risk of mobility loss in older women. The Gerontologist 2005: 58th Annual Scientific Meeting "The Interdisciplinary Mandate". Orlando, FL USA; 45: 288-9.
36. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging: An evolutionary perspective on immunosenescence. Ann NY Acad Sci 2000; 908: 244-54.
37. Paolisso G, Rizzo MR, Mazziotti G, Tagliamonte MR, Gambardella A, Rotondi M, et al. Advancing age and insulin resistance: role of plasma tumor necrosis factor-α. Am J Physiol 1998; 275: 294-9.
38. Abbatecola AM, Ferrucci L, Grella R, Bandinelli S, Bonafe M, Barbieri M, et al. Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly. J Am Geriatr Soc 2004; 52: 399-404.
39. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM. The soluble interleukin 6 receptor: mechanisms of production and implication in disease. FASEB J 2001; 15: 43-58.
40. Kawazoe Y, Naka T, Fujimoto M, Kohzaki H, Morita Y, Narazaki M, et al. Signal transducer and activator of transcription [STAT]-induced STAT inhibitor [SSI-1]/Suppressor of Cytokine Signaling 1 [SOCS1] inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 [IRS-1] phosphorylation. J Exp Med 2001; 193: 263-9.
41. Krebs DL, Hilton DJ. SOCS: Physiological suppressors of cytokine signaling. J Cell Sci 2000; 113: 2813-9.
42. Barbieri M, Ferrucci L, Ragno E, Corsi A, Bandinelli S, Bonafe M, et al. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am J Physiol Endocrinol Metab 2003; 284: E481-7.
43. Cappola AR, Xue QL, Ferrucci L, Guralnik JM, Volpato S, Fried LP. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 2003; 88: 2019-25.
44. Hotamisligil GS. Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol Diabetes 1999; 107: 119-25.
45. Feingold KR, Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992; 41(Suppl 2): 97-101.
46. Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GB Jr, Walston JD. Interventions on Frailty Working Group. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc 2004: 52: 625-34.
47. Kyriaki G. Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol 2003; 23: 1-25.
48. Vanhanen M, Koivisto K, Karjalainen L, Helkala EL, Laakso M, Soininen H, et al. Risk for non insulin dependent diabetes in the normoglycemic elderly is associated with impaired cognitive function. Neuroreport 1997; 8: 1527-30.
49. Kalmijn S, Feskens EJ, Launer LJ, Stijnen I. Kromhout D. Glucose Intolerance, hyperinsulinemia and cognitive function in a general population of elderly men. Diabetologia 1995; 38: 1096-102.
50. Taubes G. Insulin insults may spur Alzheimer's disease. Science 2003; 301: 40-1.
51. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003; 100: 4162-7.
52. Blaum CS, Xue QL, Michelon E, Semba RD, Fried LP. The association between obesity and the frailty syndrome in older women: the Women's Health and Aging Studies. J Am Geriatr Soc 2005; 53: 927-34.
53. Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, et al. Women's Health Initiative. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative observational study. J Am Geriatr Soc 2005; 53: 1321-30.
54. Visser M, Langlois J, Guralnik JM, Cauley JA, Kronmal RA, Robbins J, et al. High body fatness, but not low fat-free mass, predicts disability in older men and women: the Cardiovascular Health Study. Am J Clin Nutr 1998; 68: 584-90.
55. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res 2004; 12: 1995-2004.
56. Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, et al. Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 2007; 102: 919-25.
57. Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia, 2003; 46: 1594-603.